SCHEMBL7651882

SCHEMBL7651882

CC(C)(C(=O)O)n1c(=O)[nH]c2ccccc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.54
ADORA2A P29274 1/20 0.54
ADORA2B P29275 1/20 0.54
ADORA1 P30542 1/20 0.54
CA12 O43570 1/20 0.54
RNASEH1 O60930 1/20 0.54
ERCC1 P07992 1/20 0.54
ERCC5 P28715 1/20 0.54
FEN1 P39748 1/20 0.54
CA9 Q16790 1/20 0.54
ERCC4 Q92889 1/20 0.54
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
HPGD P15428 3/20 0.51
CYP1A2 P05177 1/20 0.50
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KMT2A Q03164 1/20 0.45
MPO P05164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656051 0.84 ADORA3 (0.50) ADORA3ADORA2AADORA2BADORA1CA12
SCHEMBL29407350 0.83 ADORA3 (0.61) ADORA3ADORA2AADORA2BADORA1CA12
SCHEMBL7650487 0.83 ADORA3 (0.61) ADORA3ADORA2AADORA2BADORA1CA12
SCHEMBL7651163 0.82 LMNA (0.44) ADORA3ADORA2AADORA2BADORA1CA12
SCHEMBL16265009 0.82 RXFP1 (0.45) ALDH1A1HPGDCYP1A2HSD17B10SMN1; SMN2
SCHEMBL8133826 0.81 KDM4E (0.45) ERCC1FEN1ERCC4ALDH1A1KDM4E
SCHEMBL7652236 0.80 SMN1; SMN2 (0.55) ADORA3ADORA2AADORA2BADORA1CA12
SCHEMBL7650104 0.80 FEN1 (0.58) FEN1KMT2AMPO
SCHEMBL7655193 0.80 CA12 (0.58) CA12CA9ALDH1A1HPGDCYP1A2
SCHEMBL7652823 0.80 CA9 (0.58) CA12CA9KDM4EHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed
EP-0988291-A1 METHOD FOR PRODUCING QUINAZOLINE-DIONES IN SOLID PHASE AND USE OF THE SAME BASF AKTIENGESELLSCHAFT (DE) 2000-03-29 EP disclosed
WO-1998056770-A1 METHOD FOR PRODUCING QUINAZOLINE-DIONES IN SOLID PHASE AND USE OF THE SAME BASF AKTIENGESELLSCHAFT (DE) 1998-12-17 WO disclosed